IRCT138903294209N1已完成未知
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugs
ational Institute of tuberculosis and lung disease0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 100 years（—）
- 性别
- All
入选标准
- •1- New cases of pulmonary or extra pulmonary tuberculosis
- •2- Older than 18 years old
- •Exclusion criteria:
- •1- HIV infection
- •2- HCV or HBV infection
- •3- Abnormal liver function tests at admission
- •4- Drug regimen without Isoniazid, Rifampin or Pirazinamide
- •5- Dissatisfaction of the patient
- •6- Pregnancy and lactation
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
Enrolling By Invitation
2 期
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsCardiac ToxicitiesHepatic ToxicityCognitive ImpairmentPeripheral NeuropathyBreast CancerNCT05595109Tanta University56
招募中
3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by adriamycin and cyclophosphamide drugs in patients with non metastatic breast cancerIRCT2017091136125N1Vice chancellor for research, Mashhad University of Medical Sciences40
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60